Rubicon Organics Announces the Results of the Annual General and Special Meeting, Appoints Chair & Grants DSUs

Core Viewpoint - Rubicon Organics Inc. held its Annual General and Special Meeting, where shareholders approved all proposed matters, including board appointments and an amended Omnibus Equity Incentive Plan [1][2][3]. Shareholder Meeting Results - A total of 31,130,021 shares were represented, constituting approximately 46.3% of the total issued and outstanding common shares [2]. - The shareholders approved the following key matters: - Setting the number of directors at eight [7]. - Electing Doris Bitz, Len Boggio, Margaret Brodie, Michael Detlefsen, Ian Gordon, Jesse McConnell, John Pigott, and Karen Proud as directors [7]. - Appointing PricewaterhouseCoopers LLP as the Company's auditors [7]. - Approval of the amended Omnibus Equity Incentive Plan with 74.7% in favor [4]. Board Changes - Len Boggio stepped down as Chair of the Board and transitioned to Chair of the Nomination and Governance Committee [5]. - Doris Bitz was appointed as the new Chair, bringing over 30 years of experience in manufacturing and consumer packaged goods [6][8]. Omnibus Equity Incentive Plan - The amended Omnibus Equity Incentive Plan allows for the issuance of various equity awards, with a maximum of 8,960,180 common shares available for grants [9][10]. - An aggregate of 1,024,576 Deferred Share Units (DSUs) was granted to independent directors as compensation for the next 12 months [11]. Company Overview - Rubicon Organics is a leader in certified organic and premium cannabis in Canada, with a vertically integrated model and strong national distribution [12]. - The company has expanded its production capacity by over 40% with the acquisition of the Hope, BC Facility, supporting growth in domestic and export markets [13]. - The focus on premium quality, innovation, and operational execution has driven consistent revenue growth and positive Adjusted EBITDA [14].